Genmab A/S (GNMSF)
OTCMKTS
· Delayed Price · Currency is USD
188.80
-8.65 (-4.38%)
May 13, 2025, 9:55 AM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $12.03 billion as of May 15, 2025. Its market cap has decreased by -34.27% in one year.
Market Cap
12.03B
Enterprise Value
11.57B
Revenue
3.14B
Ranking
n/a
PE Ratio
10.58
Stock Price
$188.80
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 415.12M to 12.03B, an increase of 2,798.62%. That is a compound annual growth rate of 14.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.62M |
| Tian'an Technology Group | 591.73M |
| Glass House Brands | 478.11M |
| CytoDyn | 475.96M |
| Elite Pharmaceuticals | 468.54M |
| Northwest Biotherapeutics | 395.18M |